Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 174

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 174
---
 Cogency Global Inc. |

II-11 NEWGENIVF LIMITED

| AUDITED CONSOLIDATED FINANCIAL STATEMENTS                                                                                  |     |     |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 1171)                                                   |     | F-2 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 6743)                                                   |     | F-4 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                               |     | F-5 |
| Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended December 31, 2024, 2023 and 2022 |     | F-6 |
| Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Years Ended December 31, 2024, 2023 and 2022  |     | F-7 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022                                 |     | F-8 |
| Notes to the Consolidated Financial Statements                                                                             |     | F-9 |

F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

| To: | The Board of Directors                
 and Shareholders of NewGenIvf Limited |

Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of NewGenIvf Limited and its subsidiaries (collectively the “Company”) as of December 31, 2021 and 2022, and the related consolidated statements of operations and comprehensive income (loss), changes in shareholders’ equity (deficit), and cash flows in each of the years for the two-year period ended December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America. Restatement of Previously Issued Financial Statements As discussed in Note 2, the Company has restated its consolidated financial statements as of December 31, 2021 and 2022, and for the years then ended. Correction of errors in the classification of subscription rece